Aclaris Therapeutics (ACRS) Stock Price, Quote, News & History | Benzinga

Aclaris Therapeutics Inc (ACRS) Stock Price, Quote, News & History

ACRSNASDAQ

Trade with Public

Trade with Public

$4.71

0.296.56%

At close: Jun 4, 5:00 PM EST

$4.49

-0.22-4.76%

After Hours: 4:14 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.46

Close

$4.71

Volume / Avg.

1.07M / 1.75M

Day Range

$4.42 - $4.77

52 Wk Range

1.34 - 5.15

Market Cap

$626.48M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

6.01%

Days to Cover

5.62

Recent Aclaris Therapeutics Inc News

Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug

Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, outperforming Pfizer's Litfulo in a severe hair loss mouse model.

Vandana Singh

Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement

Aclaris Therapeutics Inc (NASDAQ: ACRS) surgged 21.94% in after-hours trading on Tuesday after positive top-line results from its open-label Phase 2a trial.

Mohd Haider

Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy

HC Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy with a $20 price target. Aclaris gains after licensing agreement with Biosion for potential best-in-class therapies for atopic dermatitis and asthma.

Anusuya Lahiri

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-52.21M

Investing Cash Flow (TTM)

-1.69M

Financing Cash Flow (TTM)

52.19M

Free Cash Flow (TTM)

-51.45M

Capital Expenditure (TTM)

752.00K

Net Change in Cash (TTM)

-1.70M

Analyst Trends and Forecast

2

Jan

2

Mar

2

Apr

2

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$500.03M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

65.45

PB Ratio (TTM)

4.29

Earnings Yield % (TTM)

-12.70%

Earnings Yield % (FWD)

-13.04%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.03

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$28.66M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.46

Close

$4.71

Volume / Avg.

1.07M / 1.75M

Day Range

$4.42 - $4.77

52 Wk Range

1.34 - 5.15

Market Cap

$626.48M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

6.01%

Days to Cover

5.62

About

Sector

Health Care

Industry

Pharmaceuticals

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the follo...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aclaris Therapeutics (ACRS) stock?

A

You can purchase shares of Aclaris Therapeutics (NASDAQ:ACRS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aclaris Therapeutics (ACRS) competitors?

A

There are no as such competitors for Aclaris Therapeutics.

Q

What is the forecast, or price target, for Aclaris Therapeutics (ACRS) stock?

A

Aclaris Therapeutics has a consensus price target of $10.69.

Q

What is the current price for Aclaris Therapeutics (ACRS)?

A

The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $4.4856 last updated June 4, 2026 at 4:14 PM EDT.

Q

Does Aclaris Therapeutics (ACRS) pay a dividend?

A

There are no upcoming dividends for Aclaris Therapeutics.

Q

When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?

A

Aclaris Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aclaris Therapeutics (ACRS) going to split?

A

There is no upcoming split for Aclaris Therapeutics.

Q

What sector and industry does Aclaris Therapeutics (ACRS) operate in?

A

Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.